STEATOGEPATIT DIAGNOSTIKASIDA LABORATOR VA TASVIRIY TEKSHIRUVLARNI UYG‘UNLASHTIRISH
Keywords:
steatogepatit, steatoz, jigar fibrozi, laborator diagnostika, elastografiya, ultratovush, magnit-rezonans tomografiya.Abstract
Ushbu maqolada steatogepatitda laborator baholashning imkoniyatlari va cheklovlari, elastografiya va magnit-rezonans asosidagi usullar, steatoz va fibrozni bir vaqtning o‘zida tahlil qilish yondashuvlari hamda natijalarni uyg‘un talqin qilish mezonlari bayon qilinadi. Tavsiya etilayotgan integratsiyalashgan algoritm birlamchi bo‘g‘inda xavf guruhlarini tez ajratish, keraksiz invaziv aralashuvlarni kamaytirish va yuqori xavfli bemorlarni o‘z vaqtida ixtisoslashgan yordamga yo‘naltirishga xizmat qiladi.
References
European Association for the Study of the Liver; European Association for the Study of Diabetes; European Association for the Study of Obesity. EASL–EASD–EASO Clinical Practice Guidelines on the management of metabolic dysfunction-associated steatotic liver disease: Executive Summary // Diabetologia. 2024. Vol. 67. No. 11. P. 2375–2392. DOI: 10.1007/s00125-024-06196-3. PubMed+1
Rinella M. E., Lazarus J. V., Ratziu V., Francque S. M., Sanyal A. J., Kanwal F., et al. A multisociety Delphi consensus statement on new fatty liver disease nomenclature // Hepatology. 2023. Vol. 78. No. 6. P. 1966–1986. DOI: 10.1097/HEP.0000000000000520. PubMed+1
Berzigotti A., Tsochatzis E., Boursier J., Castera L., Cazzagon N., Friedrich-Rust M., et al. EASL Clinical Practice Guidelines on non-invasive tests for evaluation of liver disease severity and prognosis: 2021 update // Journal of Hepatology. 2021. Vol. 75. No. 3. P. 659–689. DOI: 10.1016/j.jhep.2021.05.025. PubMed+1
Rinella M. E., Neuschwander-Tetri B. A., Siddiqui M. S., Abdelmalek M. F., Caldwell S., Barb D., et al. AASLD Practice Guidance on the clinical assessment and management of nonalcoholic fatty liver disease // Hepatology. 2023. Vol. 77. No. 5. P. 1797–1835. DOI: 10.1097/HEP.0000000000000323. PubMed+1
